Test 2: Obesity (pt 3/3) Flashcards
What are the S/sx of Cardiac Dz in obese patients?
-Dyspnea
-Pedal Edema
-JVD
-Hepatomegaly
-Exercise intolerance
-Body habitus complicates assessment
Why are dysrhythmias common in the obese population?
Due to sinoatrial node dysfunction and fatty infiltration of the conduction system.
-ECG changes including Right-Axis deviation & RBB suggest pulmonary HTN and RV Hypertrophy
True/False: A LBBB is common in obesity.
False: A LBB Is unusual in obesity and raises suspicion of occult CAD.
-Warrants a Transthoracic Echo (TTE)
Patients with a BMI > ____ need increased doses of anticoagulants for their VTE prophylaxis.
> 50 kg/m2
Increased BMI = ______ comorbidities = _______ risk!!
Bottom line: increased BMI = increased comorbidities = increased risk!!!
What are some planning considerations to consider for the location and equipment needed in surgery for the obese patient?
-Appropriate for outpatient setting?
-Weight limits of OR Table
-BP cuffs may not fit; may require arterial line monitoring for accurate BP
-Difficult IV Access (US)
-Positioning needs
-Airway equipment (video laryngoscope; FOB)
-Additional trained personnel
-Postop monitoring of SPO2 with CPAP, possible ICU admission
What are factors that potentiate injury complications related to positioning in obese patients?
-Hypothermia
-Hypotension
-Table positioning
-Pressure from adipose tissue on orthopedic and cardiopulmonary structures
How do you prevent or mitigate risk of positioning injury in obese patients?
-Frequent palpation of pulses
-Generous padding
-Correct alignment
-Repeated inspection of extremities for color & temperature
-Treatment of the Panniculus
True/False: You don’t have to worry about weight limits with OR tables.
False: Ensure the OR table can support the weight of the patient - high risk for falls and table failure!!!
What are the pharmacokinetic changes associated with obesity?
-Increased fat mass
-Increased cardiac output
-Increased blood volume
-Increased lean body weight
-Changes in plasma protein binding
-Reduced total body water
-Increased renal clearance
-Increased volume of distribution of lipid-soluble drugs
-Abnormal liver function
-Decreased pulmonary function
Give water-soluble drugs according to _____.
IBW
Give lipid-soluble drugs according to ______.
TBW
Can you give inhalational agents to obese patients?
Yes; newer inhalational agents (Des/Sevo) have excellent recovery profiles
-Des is less soluble than sevo; clinical differences are minimal
True/False: You can never give Nitrous Oxide to an obese patient.
False: Nitrous oxide is being increasingly used in obese patients as a volatile-sparing adjunct.
-Can be used unless a high O2 requirement precludes its administration
What are some benefits to using Nitrous Oxide in obese patients?
-Has the potential to reduce chronic postop pain
-The 2nd gas effect of N2O at induction & emergence can accelerate uptake and elimination of the volatile agent.